Wikipedia -WSS

Wikipedia

author：leisure time 2025-10-01 17:42:33 - browse：27

A purple number 3 with an eye is surrounded by smaller, black number 3s on a green background — 3 to watch coverage from STAT — Christine Kao/STAT

Every winter, like Punxsutawney nobles, biotech’s many thought leaders gather for the J.P. Morgan Healthcare Conference to pick apart the year that was and prognosticate about the one to come. The consensus, in good markets and bad, is almost always cautious optimism for boom times ahead, a prediction that in recent years has had groundhog-level accuracy.

But after two years of steady decline, 2024 might finally prove them right. Biotech is on the upswing, driven by the rise of some headline-grabbing medicines, the advance of cutting-edge technologies, and a few reminders that big drug companies are still willing to pay billions of dollars for small ones.

Here are three major themes that we expect to drive the news in 2024 and determine whether biotech’s comeback is a sustainable trend or an interest-rate phenomenon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： AstraZeneca to buy developer of next

explore

WSS

The high cost of giving birth even with insurance

Duchenne breakthrough therapy leaves behind pioneering families

CVS Caremark has created a new ploy: the drug ‘rebate credit’

As demand for Covid shots wanes, Moderna seeks its next success

Creating egg and sperm cells from stem cells raises ethical issues

Virtual Event: March of the Biosimilars

knowledge

Wikipedia

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Argenx readies a blockbuster opportunity with drug for autoimmune disease

23andMe had bad news about my health. I wish a person had delivered it

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Peter Hotez and the public health issue of online harassment

Anesthesiologist group: stop taking Ozempic before surgery

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Anesthesiologist group: stop taking Ozempic before surgery

After affirmative action ruling, medical educators look to 'holistic review'

Wikipedia

Heart attack and stroke risk calculators need revising

Virtual Event: March of the Biosimilars

ChatGPT in medicine: STAT answers readers' burning questions

5 to watch: Tech startups trying to solve health care's staffing crisis

Neuroscience’s long legacy of racism

Apple is now the first public company to be valued at $3 trillion

leisure time

focus

explore

hotspot